(845) 986-2777
24 Main Street, Warwick, NY 10990
(212) 203-7710
450 7th Avenue, 33rd Fl, New York, NY 10123

Stryker Marks Robotic Joint Replacement Milestone

Stryker Marks Robotic Joint Replacement Milestone

For more information, please contact The Ahearne Law Firm, PLLC for an initial consultation and case evaluation. Call nationwide at (845) 986-2777.

Stryker Orthopaedics celebrated a landmark moment this month as the 100,000th cumulative robotic-arm assisted procedure in the U.S. was performed using the Mako System. This advanced robotic technology transforms the way joint replacement surgery is performed, enabling surgeons to have a more predictable surgical experience with increased accuracy.

Through CT-based 3D modeling of bone anatomy, surgeons can use the Mako System to create a personalized surgical plan and identify the implant size, orientation and alignment based on each patient’s unique anatomy. The Mako System also enables surgeons to virtually modify the surgical plan intra-operatively and assists the surgeon in executing bone resections.

Earlier this year, Stryker announced the commercial launch of its highly anticipated robotic-arm assisted application, Mako Total Knee, for use with the market leading Triathlon Total Knee System. This latest advancement distinguishes the Mako System as the first and only robotic technology that can be used across the joint replacement service line to perform total knee, partial knee and total hip replacements. These treatment options are designed to relieve the pain caused by joint degeneration due to osteoarthritis.

Stryker Orthopedics has had success with its Mako system for partial knee replacement. By selectively targeting the part of the knee damaged by osteoarthritis, a surgeon can replace the diseased part of the knee while sparing the healthy bone and ligaments surrounding it. The Mako technology provides the surgeon with a patient-specific 3D model to pre-plan the replacement. During surgery, the surgeon guides the Mako robotic-arm based on your the plan, allowing the surgeon to remove only the diseased bone, preserving healthy bone and soft tissue, and assisting the surgeon in positioning the implant based on the patient’s anatomy.

Stryker CEO Kevin Lobo:

With robotics and 3D printing, we believe we have the lead on both of those areas and those are things we can talk about that differentiate us from our competition. [They] are not a huge component of our growth or our actual dollar sales, but we believe they are the ones that are causing that extra piece of growth and in a different view of Stryker for the future.”

As mentioned in our March 14th blog post, innovative product designs and advancements in robotics, computer-navigated surgeries, smart implants, nanotechnology, 3D printing, biologics and tissue engineering will contribute to market growth. Hospitals are adopting robotic surgical devices to be used by trained physicians to improve their outcomes. Many universities worldwide have research programs in robotics and are awarding degrees on the subject, leading to roboticists increasingly being hired by top companies to link mobile robots into existing IT systems.The hip and knee surgical robot device market stood at $84 million in 2015, and is anticipated to reach $4.6 billion by 2022.

However, despite the success with the Mako system, Stryker continues to be plagued by thousands of lawsuits in connection with its metal-on-metal hips in connection with its Rejuvenate and ABG II hip stem implants and LFIT V40 femoral head.

Global Artificial Joints Market

As mentioned in our May 18th blog post, the global artificial joints market, valued at approximately $16 Billion in 2015, is expected to reach over $25 Billion by 2024.

Artificial joints, also known as prosthetics or implants, are devices surgically implanted to replace a natural joint to correct joint abnormalities and to enhance joint function. The global artificial joints market is primarily comprised of knee, hip, shoulder implants. As of 2015, knee implants hold the largest market share. Factors such growing aging population, consequently increasing incidence of age related musculoskeletal diseases such as arthritis and osteoporosis, rising obese population are majorly contributing to the demand for of knee and hip replacement surgeries, and consequently respective implants.

Artificial joints are primarily made of ceramic, alloy or oxinium. As of 2015, ceramic implants were the largest revenue generating segment, with further growth anticipated.  Factors such as reduced risk of osteolysis, chemical inertness, resistance to corrosion, non-allergic properties and biocompatibility drive the ceramic artificial joints market. However, a trend of combining different materials has been noticed.

The artificial joints market is currently dominated by North America, with California, Florida and Texas as the major revenue-contributing regions. Europe is the second-largest revenue-generating segment in the global artificial joints market, with Austria, Belgium, Germany and Switzerland as the prime drivers. Factors such as increasing demand for the minimally invasive surgeries, higher cost of replacement devices, growth in health expenditure and technological advancement drive the market growth in Europe.

The artificial joints market is highly competitive and comprises a large number of manufacturers, led by Aesculap AG, AK Medical, Arthrex, Zimmer Biomet, Depuy Synthes (Johnson & Johnson), DJO Global, Inc., Exactech, Inc., Globus Medical, JRI Orthopaedics, Medtronic, Inc., NuVasive, Inc., SAMO, Smith & Nephew, Stryker Corp., and Zimmer Biomet.

Market growth will continue due to the continuous increase in the obese population, unhealthy eating habits, the rising geriatric population, the higher cost of implantable joints, technological advancement, and the upsurge in funding by government agencies and private organizations in healthcare. The rising incidence of osteoarthritis and arthritis will also contribute as osteoarthritis is one of the ten most disabling diseases in developed countries. Interestingly, adults younger than 60 undergoing total knee and hip replacements also contribute to market growth. However, factors such as the high cost of surgery, post-surgical complications and the increasing awareness of certain non-surgical treatments may negatively impact market growth.

Artificial Joints Market to Grow Over 50% by 2024

#Stryker #mako #joint #robotics #surgery #implant

If you or a family member have had hip, knee, shoulder or elbow replacement surgery, or have had revision surgery to remove and replace a hip, knee, shoulder or elbow implant, you and/or your family member may be entitled to money damages.

For more information, please contact The Ahearne Law Firm, PLLC for an initial consultation and case evaluation. Call nationwide at (845) 986-2777.

Leave a Reply